Phase 2 Start~month

Phase 2 Start: A Prospective, Multicenter, Open-label Two Cohort Study Evaluating the Safety and Efficacy of Select

Indication
Hepatocellular Carcinoma (HCC)

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Start: A Prospective, Multicenter, Open-label Two Cohort Study Evaluating the Safety and Efficacy of Select — WOK Phase 2 Start | BioSniper